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Background 
MassHealth’s mission is to improve the health outcomes of our diverse members and their 
families by providing access to integrated health care services that sustainably and equitably 
promote health, well-being, independence and quality of life. In support of that mission, 
MassHealth provides broad coverage of medically necessary health care services to its 
members. In light of the state of emergency declared in the Commonwealth due to the 2019 
novel Coronavirus (COVID-19) outbreak, MassHealth is introducing additional flexibilities 
for coverage and billing related to COVID-19, as further described in this bulletin. 
This bulletin contains requirements for Accountable Care Partnership Plans (ACPPs), Managed 
Care Organizations (MCOs), One Care Plans, Senior Care Organizations (SCOs), and the 
behavioral health vendor (collectively referred to as “managed care plans”) in response to the 
coronavirus disease (COVID-19) outbreak.  These requirements align with certain coverage and 
payment policies of MassHealth’s Fee-for-Service program, Primary Care Clinician (PCC) Plan 
and Primary Care Accountable Care Organizations relating to pharmacy services, referrals, and 
payment.  
Managed care plans should refer to Managed Care Entity Bulletin 21 as well as All Provider 
Bulletins 289 and 291 for additional requirements that apply during the state of emergency.  
Managed care plans must ensure that they deliver all covered services in an amount, duration and 
scope that is no more restrictive than the MassHealth fee-for-service program.  Managed care 
plans should stay up to date on any changes to the amount, duration, and scope of services that 
MassHealth may announce via subsequent bulletins or guidance. 
Program of All-inclusive Care for the Elderly (PACE) organizations should follow the guidance set 
forth in this bulletin, Managed Care Entity Bulletin 21, and in All Provider Bulletins 289 and 291 
and any subsequent guidance when delivering services to MassHealth members. 
Managed care plans should notify their provider network of these changes as appropriate, 
consistent with the plan’s current business practices. 
The requirements described in this Bulletin will remain effective for the duration of the 
state of emergency declared through Executive Order No. 591. 
More information tied to COVID-19 pharmacy changes can be found online on the 
MassHealth Drug List (MHDL) available at 
https://masshealthdruglist.ehs.state.ma.us/MHDL/. A forthcoming section of the MHDL 
will specifically address all COVID-19 related items. 
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Pharmacy Requirements 
This section sets forth pharmacy-related requirements that have been included in All Provider 
Bulletins 289 and 291 as well as Pharmacy Facts 142 and 143. 
 
For all pharmacy guidance provided herein and related All Provider Bulletins and Pharmacy 
Facts, One Care Plans, SCOs, and PACE organizations must provide these flexibilities for their 
enrollees without Medicare coverage (e.g., Medicaid only members). In addition, One Care Plans, 
SCOs, and PACE organizations must provide these flexibilities for all enrollees for pharmacy 
products other than Part D products. 
90 Days’ Supply 
ACPPs and MCOs must allow pharmacies (at the pharmacies’ discretion) to dispense up to a 
90-day supply of prescription drugs if requested by a MassHealth member or that member’s 
prescriber as long as sufficient quantity remains on the prescription to support the quantity 
being filled. 
Please note that this policy does not apply to drugs that require Prescription Monitoring 
Program (PMP) reporting (other than schedule IV benzodiazepines and hypnotics), 
antibiotics, intravenous medications and certain other drugs designated by MassHealth 
(e.g., drugs for which quantity limits have been individually established for clinical 
reasons). 
If a pharmacist believes that dispensing up to a 90-day supply of any drug not covered by 
the policy would be in the best interest of a MassHealth member, they may seek an override 
through current processes established by the ACPPs and MCOs for such requests. 
Early Refills 
MassHealth ACPPs and MCOs must allow early refills of existing prescriptions for drugs as long 
as at least one refill remains on the prescription. 
Removal of Prior Authorization on Certain Therapeutic Classes 
MassHealth ACPPs and MCOs must remove Prior Authorization (PA), if any, on the following 
drugs and drug classes: 
Drugs and Therapeutic classes to have PA removed: 
• Aminoglycoside Agents Inhaled 
• Antibiotics – Oral and Injectable 
• Antifungals – Oral and Injectable 
• Respiratory Agents, Oral and Inhaled 
• Sublocade 
MassHealth also strongly encourages ACPPs and MCOs to reconsider any PA requirements 
that may be difficult to achieve or unrealistic to attempt during this state of emergency (e.g., 
step therapy which requires medications that cause systemic immunosuppression). Given 
that members are asked to remain home when possible, this includes any lab requirements 
needed for approval or recertification of a prescription.
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Policy on Hydroxychloroquine and Chloroquine 
For dates of service on or after March 26, 2020, MCOs and ACPPs must adopt the following 
policies concerning the prescribing and dispensing of chloroquine and hydroxychloroquine.  
Pharmacy claims for chloroquine and hydroxychloroquine should process without a new PA for 
individuals with existing prescriptions for lupus, malaria, or rheumatic conditions. Consistent 
with All Provider Bulletin 289, in such circumstances pharmacies may dispense up to a 90-day 
supply if requested by a MassHealth member or prescriber as long as sufficient quantity remains 
on the prescription to support the quantity being filled. 
Individuals who have or are suspected to have COVID-19 or who have new prescriptions for 
lupus, malaria, or rheumatic conditions must go through a PA process before chloroquine and 
hydroxychloroquine can be dispensed. If a MassHealth member or HSN patient is approved for 
COVID-19, pharmacies must dispense up to a 14-day supply. If a MassHealth member or HSN 
patient is approved for other diagnoses, pharmacies may dispense up to a 90-day supply if 
requested by the MassHealth member, HSN patient, or prescriber as long as sufficient quantity 
remains on the prescription to support the quantity being filled. 
Albuterol Inhalers 
MassHealth ACPPs and MCOs must remove any requirement that brand name ProAir be 
used when dispensing an albuterol inhaler. Claims for both brand ProAir and its generic 
equivalent must be accepted. 
Extension for Soon-to-be Expired PAs 
MassHealth ACPPs and MCOs must allow an extension of 60 days for any drug prior 
authorizations due to expire in the next 30 days. Maintenance medications should be 
prioritized for extensions. 
Mail Order Prescriptions and Signature Requirements 
MassHealth ACPPs and MCOs shall reimburse any willing pharmacy for mail order 
prescriptions. Furthermore, ACPPs and MCOs must waive any signature requirements for 
prescription drugs, whether associated with in-person pickup or delivery, in order to 
maintain a “contactless” transaction. 
Coverage and Payment Policies 
As set forth in Managed Care Entity Bulletin 21, managed care plans must take all necessary 
steps to enable their enrollees to obtain medically necessary and appropriate testing and 
treatment that will help fight the spread of this disease. As such, managed care plans must not 
impose any referral requirements for any medically necessary covered services, regardless of 
whether such services are related to the testing or treatment of COVID-19. 
Additionally, managed care plans should process and pay every clean claim as expeditiously as 
possible and should not systematically hold payment on any clean claims for any provider type.
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MassHealth Website 
For all COVID-19 pharmacy-related updates, please visit the new webpage “COVID-19 Pharmacy 
Program” on the MassHealth website at https://masshealthdruglist.ehs.state.ma.us/MHDL/  
This bulletin is available on the MassHealth website at www.mass.gov/masshealth-
provider-bulletins. 
To sign up to receive email alerts when MassHealth issues new bulletins and transmittal 
letters, send a blank email to join-masshealth-provider-pubs@listserv.state.ma.us. No text 
in the body or subject line is needed. 
Questions 
If you have any questions about the information in this bulletin, please contact the 
MassHealth Customer Service Center at (800) 841-2900, email your inquiry to 
providersupport@mahealth.net, or fax your inquiry to (617) 988-8974. 
